Home Technology News Investors Contact Us Search



 
News


  • SureGene is awarded $200,000 R&D Voucher from the Kentucky Science and Technology Corporation.

  • SureGene is awarded a Phase Zero SBIR Grant from the Kentucky Science and Engineering Foundation.

  • SureGene awarded $497,000 SBIR Phase One for Schizophrenia Risk Assessment Test

  • Kentucky awards SureGene $510,000 Economic Incentive Package

  • SureGene earns $100,000 SBIR Phase I match through innovative KY program


    • Publications


  • Brennan MD, Condra J. Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2005 November 5;139(1):69-72.

  • Condra, Jodi A. a; Neibergs, Holly b; Wei, Wei a; Brennan, Mark D., Psychiatric Genetics. 17(5):292-298, October 2007 Evidence for two schizophrenia susceptibility genes on chromosome 22q13


    • Presentations


  • Dr. Brennan presents at Next Generation Sequencing Conference

    		•
    Copyright SureGene LLC